NASDAQ: ULBIUltralife Revenue
Ultralife revenue was $191.16M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $48.5M, up 11.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ULBI annual revenue was $191.2M, with 16.2% growth year-over-year.
ULBI past revenue growth
How has ULBI's revenue growth performed historically?
Company
16.24%
Industry
157.1%
Market
89.29%
ULBI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ULBI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ULBI's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
ULBI revenue history
Current Revenue
$191.2M
Current Earnings
-$5.9M
Current Profit Margin
-3.1%
Be the first to know when ULBI announces revenue.
ULBI Revenue History By Year
| ULBI Yearly Revenue | ULBI Revenue | ULBI Change | ULBI Revenue Growth |
|---|---|---|---|
| 2025-12-31 | $191.16M | $26.70M | +16.24% |
| 2024-12-31 | $164.46M | $5.81M | +3.66% |
| 2023-12-31 | $158.64M | $26.80M | +20.33% |
| 2022-12-31 | $131.84M | $33.57M | +34.17% |
| 2021-12-31 | $98.27M | -$9.45M | -8.77% |
| 2020-12-31 | $107.71M | $917.00k | +0.86% |
| 2019-12-31 | $106.80M | $19.61M | +22.49% |
| 2018-12-31 | $87.19M | $1.66M | +1.94% |
| 2017-12-31 | $85.53M | $3.07M | +3.72% |
| 2016-12-31 | $82.46M | $6.03M | +7.89% |
| 2015-12-31 | $76.43M | $9.93M | +14.94% |
| 2014-12-31 | $66.49M | -$12.34M | -15.65% |
| 2013-12-31 | $78.84M | -$22.82M | -22.45% |
| 2012-12-31 | $101.66M | -$34.08M | -25.11% |
| 2011-12-31 | $135.74M | -$31.08M | -18.63% |
| 2010-12-31 | $166.82M | $12.52M | +8.12% |
| 2009-12-31 | $154.30M | -$100.41M | -39.42% |
| 2008-12-31 | $254.70M | $117.10M | +85.11% |
| 2007-12-31 | $137.60M | $44.05M | +47.09% |
| 2006-12-31 | $93.55M | $23.05M | +32.69% |
| 2005-12-31 | $70.50M | -$27.68M | -28.19% |
| 2004-12-31 | $98.18M | $18.73M | +23.58% |
| 2003-12-31 | $79.45M | $46.94M | +144.35% |
| 2002-06-30 | $32.52M | $8.35M | +34.57% |
| 2001-06-30 | $24.16M | -$351.00k | -1.43% |
| 2000-06-30 | $24.51M | $3.45M | +16.38% |
| 1999-06-30 | $21.06M | $4.67M | +28.51% |
| 1998-06-30 | $16.39M | $450.00k | +2.82% |
| 1997-06-30 | $15.94M | $840.00k | +5.56% |
| 1996-06-30 | $15.10M | $457.72k | +3.13% |
| 1995-06-30 | $14.64M | $9.33M | +175.58% |
| 1994-06-30 | $5.31M | N/A | N/A |
Ultralife Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.